Navigation Links
Inverness Medical Innovations Announces Fourth Quarter 2007 Results
Date:2/20/2008

8.9 million charge for the year ended December 31,

2006 includes: $9.5 million charged to cost of sales, $2.9 million

charged to research and development and $0.8 million charged to

selling, general and administrative expense, offset by a $4.3

million net foreign currency gain resulting from the closure of our

CDIL operation in Ireland recorded to other income. These charges

have been excluded from net income or loss because they have a

significant impact on results yet do not occur on a consistent or

regular basis in the Company's business.

(c) Amortization expense of $62.2 million and $21.8 million for the year

2007 and 2006 GAAP results, respectively, including $24.1 million

and $11.2 million charged to cost of sales, $2.9 million and $3.3

million charged to research and development, $34.8 million and $7.1

million charged to selling, general and administrative expense, and

$0.4 million and $0.2 million charged to other expense in the

respective periods.

(d) Compensation costs of $57.4 million and $5.5 million associated with

stock-based compensation expense, including $0.6 million and $0.4

million charged to cost of sales, $2.2 million and $1.4 million

charged to research and development and $54.6 million and $3.7

million charged to selling, general and administrative. The $57.5

million charged to selling, general and administrative during the

year-ended December 31, 2007 includes $45.2 million of costs

associated with stock option acceleration and conversion in

connection with our recent acquisition of Biosite.

(e) A net loss of $3.5 million resulting from a loss of $4.9 million

associated with management's decision to dispose of our SMB research

ope
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
2. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
3. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
7. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
8. Inverness - Chemogen Establish Exclusive License for TB Antibodies
9. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
10. B-Line Medical and Immersion Medical Announce Partnership
11. MIT researcher addresses biomedical engineering challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Mathematic studies at the ... , and funded by the Jeffrey Epstein VI Foundation ... can be visually identified for elimination. These aggressive cells are ... which shows a topological map of what to look for ... research, for while tumor cells can be extracted from biopsy, ...
(Date:8/21/2014)... Pursuit Solutions ( http://www.pursuit-solutions.com ), ... services for Life Sciences sales and marketing organizations, ... New Commercial Sales Models” by Peter Robinson, co-founder ... article examines some innovative models used to improve ... in the pharmaceutical market. Robinson grades the industry ...
(Date:8/21/2014)... On Wednesday of last week RENU 28, the world's ... became available for purchase in Australia and New Zealand, and ... 28 works is, if you think about the definition of ... cellular renewal within your body. If you think about the ... cellular renewal. What RENU 28 does is it works with ...
(Date:8/20/2014)... succeeded in measuring vibrational motion of a single molecule ... vibration of a single molecule differs from the behaviour ... performed at the University of California, Irvine, where post-doctoral ... as a visiting fellow under professor Vartkess A. Apkarian, ... was lead by Professor Eric O. Potma. The results ...
Breaking Biology Technology:Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2RENU 28 Skin Care Now Available in Australia and New Zealand 2Seeing a molecule breathe 2
... Kingdom and GAITHERSBURG, Md., Oct. 29 /PRNewswire/,-- ... name to MedImmune to,reflect AstraZeneca,s vision for ... will unite the resources and expertise from ... activities within the AstraZeneca,Group, under the "MedImmune" ...
... the Innovator in,Ultrasound for more than 50 years, announced ... for advanced cardiac and,vascular imaging, the ProSound Alpha 10 ... American Heart Association, at the Orange County,Convention Center in ... 7 and the Alpha 10 incorporate all of the ...
... WaferGen Biosystems,Inc. (OTC Bulletin Board: WGBS), a ... and stem cell research systems,today announced that Mr. ... a corporate presentation at the Acumen BioFin Rodman,& ... be held,November 5 - 7, 2007, at the ...
Cached Biology Technology:AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune 2ALOKA to Introduce New 'ProSound' Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida 2ALOKA to Introduce New 'ProSound' Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida 3WaferGen to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
(Date:8/20/2014)... awarded the Oklahoma Medical Research Foundation a five-year, $14.5 ... the bacteria,s effects on humans. , For 10 ... have studied the human immune response to anthrax bacteria ... The original funding came soon after anthrax-laced letters killed ... terrorist attacks of Sept. 11, 2001. , The ...
(Date:8/20/2014)... the past few years, Virginia Tech,s Wu Feng has ... grant from the "Computing in the Cloud" program, and ... $6 million award from the Air Force on "big ... NSF and the National Institutes of Health on "big ... together the "parallel computing" aspects from each grant, he ...
(Date:8/20/2014)... for electronically manipulating the flight muscles of moths and ... those muscles. The work opens the door to the ... emergency response. , "In the big picture, we want ... moths for use in applications such as search and ... of electrical and computer engineering at NC State and ...
Breaking Biology News(10 mins):$14.5 million grant awarded to continue anthrax studies 2The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4Research paves way for development of cyborg moth 'biobots' 2
... for creating chemical reactions between single molecules, scientists ... (NIST) have employed microfluidicsthe manipulation of fluids at ... molecules of interest. By combining this new microfluidic ... multiple droplets and cause their molecular contents to ...
... Researchers at the National Institute of Standards and ... other government agencies, have produced a new reference ... used as a hardener in high-performance alloys and ... fatal illness. The new reference material is expected ...
... that dust from a nearby construction zone will harm your ... confirm your suspicions or better yet, set your mind at ... Sandra Chudnovsky, of TAU,s Department of Geography have developed a ... ― to help families and authorities monitor the quality ...
Cached Biology News:New nanochemistry technique encases single molecules in microdroplets 2New beryllium reference material for occupational safety monitoring 2Tel Aviv University invention busts dust 2Tel Aviv University invention busts dust 3
... Blot Strong Antibody Stripping Solution is effective ... that have been developed with chemiluminescence or ... not recommended for stripping colorimetric substrates (TMB, ... possible to effectively remove substrates that precipitate ...
... supplied as a 5x solution. Designed ... membrane-bound proteins without destroying antigenic binding ... radioisotopic signals from blots. Not recommended ... as a 5X solution sufficient to ...
... This marker is specifically designed ... (urea) IEF. The four proteins in ... provide a diagonal pattern across a ... 7.6 to 3.8. ...
High-throughput DNA preparation and end sequencing of BAC libraries. 3730xl DNA sequencers. LIMS tracking utilizing Geospiza's Finch system. Full-length BAC sequencing also available. Our expertise h...
Biology Products: